Microbot Medical Inc.
MBOT
$4.11
$0.22995.93%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -41.99% | -9.70% | -7.55% | -31.44% | -7.78% |
Total Depreciation and Amortization | -14.29% | -46.43% | -25.71% | 15.00% | -46.15% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -64.35% | -43.49% | -88.47% | 5.64% | -2.93% |
Change in Net Operating Assets | 388.96% | -2.64% | 220.31% | -69.90% | 146.97% |
Cash from Operations | -31.48% | -18.76% | 7.14% | -66.71% | -5.56% |
Capital Expenditure | -125.00% | 7.14% | -240.00% | 100.00% | 60.00% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -209.24% | -1,854.09% | -49.15% | 105.50% | 192.61% |
Cash from Investing | -210.37% | -1,833.80% | -49.44% | 105.44% | 191.58% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 129.12% | 1,060.03% | -- | -- | -69.13% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 129.12% | 1,060.03% | -- | 493.17% | -69.13% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -33.23% | 107.80% | 132.04% | 54.74% | -63.50% |